BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32124002)

  • 1. The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology.
    Matias-Guiu X; Stanta G; Carneiro F; Ryska A; Hoefler G; Moch H;
    Virchows Arch; 2020 Apr; 476(4):491-497. PubMed ID: 32124002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologists and liquid biopsies: to be or not to be?
    Hofman P; Popper HH
    Virchows Arch; 2016 Dec; 469(6):601-609. PubMed ID: 27553354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical considerations for modern molecular pathology.
    Vos S; van Diest PJ; Ausems MG; van Dijk MR; de Leng WW; Bredenoord AL
    J Pathol; 2018 Dec; 246(4):405-414. PubMed ID: 30125358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changing role of pathologists from morphologists to molecular pathologists in the era of precision medicine.
    Masood S
    Breast J; 2020 Jan; 26(1):27-34. PubMed ID: 31876097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Somatic Curation and Interpretation Across Laboratories (SOCIAL) project-current state of solid-tumour variant interpretation for molecular pathology in Canada.
    Spence T; Sukhai MA; Kamel-Reid S; Stockley TL
    Curr Oncol; 2019 Dec; 26(6):353-360. PubMed ID: 31896933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular tumor board in uro-oncology-from a pathologist's view].
    Gaisa NT; Kristiansen G; Perner S
    Urologe A; 2019 Jul; 58(7):747-751. PubMed ID: 31049636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging significance of secondary germline testing in cancer genomics.
    Mandelker D; Zhang L
    J Pathol; 2018 Apr; 244(5):610-615. PubMed ID: 29293272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized cancer medicine and the future of pathology.
    Moch H; Blank PR; Dietel M; Elmberger G; Kerr KM; Palacios J; Penault-Llorca F; Rossi G; Szucs TD
    Virchows Arch; 2012 Jan; 460(1):3-8. PubMed ID: 22143935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Pathology in the Era of Personalized (Precision) Medicine: A Brief Review.
    Vranic S; Gatalica Z
    Acta Med Acad; 2021 Apr; 50(1):47-57. PubMed ID: 34075763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision diagnostics: integration of tissue pathology and genomics in cancer.
    Sharma S; George P; Waddell N
    Pathology; 2021 Dec; 53(7):809-817. PubMed ID: 34635323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time for change: a new training programme for morpho-molecular pathologists?
    Moore DA; Young CA; Morris HT; Oien KA; Lee JL; Jones JL; Salto-Tellez M
    J Clin Pathol; 2018 Apr; 71(4):285-290. PubMed ID: 29113995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "The leading role of pathology in assessing the somatic molecular alterations of cancer: Position Paper of the European Society of Pathology": letter to the Editor.
    Dinjens WNM; Ligtenberg MJL; van Wezel T; Schuuring E; Dubbink HJ
    Virchows Arch; 2021 Feb; 478(2):379-380. PubMed ID: 32761392
    [No Abstract]   [Full Text] [Related]  

  • 13. Uncovering Hereditary Tumor Syndromes: Emerging Role of Surgical Pathology.
    Agaimy A; Hartmann A
    Semin Diagn Pathol; 2018 May; 35(3):154-160. PubMed ID: 29395463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants.
    He MM; Li Q; Yan M; Cao H; Hu Y; He KY; Cao K; Li MM; Wang K
    Genome Med; 2019 Aug; 11(1):53. PubMed ID: 31443733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Pathology of Lung Cancer.
    Roy-Chowdhuri S
    Surg Pathol Clin; 2021 Sep; 14(3):369-377. PubMed ID: 34373089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular predictive testing in precision oncology: The Italian experience.
    Vigliar E; Iaccarino A; Sciortino M; De Luca C; Malapelle U; Bellevicine C; Troncone G
    Cancer Cytopathol; 2020 Sep; 128(9):622-628. PubMed ID: 32885914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidance for laboratories performing molecular pathology for cancer patients.
    Cree IA; Deans Z; Ligtenberg MJ; Normanno N; Edsjö A; Rouleau E; Solé F; Thunnissen E; Timens W; Schuuring E; Dequeker E; Murray S; Dietel M; Groenen P; Van Krieken JH; ;
    J Clin Pathol; 2014 Nov; 67(11):923-31. PubMed ID: 25012948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical Cancer Genetics: A guide for the pathologist].
    Basset N; Desseignés C; Boucher C; Coulet F; Benusiglio PR
    Ann Pathol; 2020 Apr; 40(2):63-69. PubMed ID: 32046877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological control for molecular testing: a practical approach.
    Gullo I; Marques A; Pinto R; Cirnes L; Schmitt F
    J Clin Pathol; 2021 May; 74(5):331-333. PubMed ID: 32763918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.